{"id":55,"date":"2019-11-04T13:22:55","date_gmt":"2019-11-04T11:22:55","guid":{"rendered":"https:\/\/www.imunomed.ro\/?p=55"},"modified":"2019-11-04T16:06:10","modified_gmt":"2019-11-04T14:06:10","slug":"perspective-terapeutice-in-parazitozele-din-africa","status":"publish","type":"post","link":"https:\/\/www.imunomed.ro\/?p=55&lang=ro","title":{"rendered":"Perspective terapeutice \u00een  parazitozele din Africa"},"content":{"rendered":"<p>\u00cen parazitozele tisulare severe din zonele tropiale, cele ce evolueaz\u0103 spre casexie \u0219i exitus, mai ales la copii, probabil c\u0103 sunt implica\u021bi mai mul\u021bi factori: ac\u021biunes direct\u0103 a produ\u0219ilor metabolici parazitari, ac\u021biunea sistemului imunitar prin citokine (TNF, IFN) \u0219i ac\u021biunea indirect\u0103 imunologic\u0103 prin cross-reactivity (exemple \u2013 cardiopatia cronic\u0103, esofagita \u0219i megacolonul din boala Chagas, rezultat\u0103 prin cross-reactivity \u00eentre Irypanosoma cruzi \u0219i structuri ale neuronului; oncercus volvulus osed\u0103 un antigen de cross-reactivity cu retina.<br \/>\nMecanismul principal imunologic de ap\u0103rare antiparazitar\u0103 pare a fi linie TH1 (IFN \u0219i TNF\u03b1) implicat\u0103, mai ales, \u00een formele larvare \u0219i linie TH2 (IL3, IL4, IL5), \u00een forme helmintiazice.<br \/>\n\u00cen Europa, evolu\u021bia parazitozelor este mult mai bun\u0103. Partajul teniilor se poate \u00eentinde pe o perioad\u0103 de ani de zile f\u0103r\u0103 afectarea st\u0103rii generale, \u00een timp ce filariozele africane produc casexie \u0219i letargie. Schemele de tratament, \u00een Europa, sunt mult mai scurte \u0219i eficiente deci probabil c\u0103, \u00een Africa, exist\u0103 un grad de imunodeficien\u021b\u0103, mai ales la copii.<br \/>\nDup\u0103 observa\u021biile imunologilor, \u00een filarioze, TH1 are un defect de activare \u0219i proliferare \u00een imunitatea celular\u0103, \u00een timp ce r\u0103spunsul umoral augmenteaz\u0103, mai ales, pe linia Ig G4. Filariozele pot secreta prostaglandine cure depresiv asupra reac\u021biei inflamatorii.<br \/>\n\u00cen zonele tropicale, unde expunerea la radia\u021bii U.V este mare, s-ar putea s\u0103 fie un grad de imunodeficien\u021b\u0103 rezultat\u0103 printr-un exces de vitamie D3 (colecalcifere). \u00cen aceste zone este mai sc\u0103zut\u0103 inciden\u021ba unor boli autoimune, \u00een cate vitamina D3 are rol modulator \u00een artrita reumatismal\u0103, scleroza multipl\u00ee \u0219i diabetul zaharat insulinodependent. Vitamina D a fost propus\u0103 a se asocia schemelor de glucorticoizi deoarece are efect imunomodulator.<br \/>\nCombina\u021bia vitaminei D3 activ\u0103 + Dexametazon\u0103, puse \u00eentr-un mediu de cultur\u0103 cu celule dentritice derivate din monocite, dezvlt\u0103 un efect sinergic de inhibare a maturiz\u0103rii celulelor dentritice.<br \/>\nVitamina D func\u021bioneaz\u0103 ca reglator al r\u0103spunsului imun; pe suprafa\u021ba celulelor mononuclear sangvine se eviden\u021biaz\u0103 receptori pentru vitamina D (VDR). Suplimentarea cu forma activ\u0103 hidroxilat\u0103 1,25 dihidroxicolecalciferol [1,25 \u2013 (OH)2D3] are rol benefc \u00een artrita reumatoid\u0103, diabetul zaharat juvenil \u0219i encefalomielita alergic\u0103.<br \/>\n\u0218i limfocitul TH prezint\u0103 VDR; vitamina D3 are ac\u021biune inhibitorie pe limfocitul TH1 \u0219i ac\u021biune stimulatorie pe TH2. Vitamina D poate fi un reglator al transcrip\u021biei citokinetelor TH.<br \/>\nS-ar putea ca pacien\u021bii din aceste zone s\u0103 prezinte \u0219i un dezechilibru al acizilor gra\u0219i esen\u021biali. Ace\u0219tia sunt cunoscu\u021bi ca av\u00e2nd propriet\u0103\u021bi imunomodulatoaredar este importat ca acizii gra\u0219i esen\u021biali s\u0103 fie de origine vegetal\u0103. Ei pot fi ob\u021binu\u021bi, \u00een cadrul dietelor vegetariene, prin conversia acidului linoleic (din floarea soarelui) \u00een acid arahidonic.<br \/>\nSursele de acizi gra\u0219i esen\u0219iali 3 sunt mai greu accesate (ulei de in \u0219i soia) dar ei pot fi ob\u021binu\u021bi din ulei de floarea soarelui, prin transformare (conversia se produce u\u0219or, dac\u0103 dieta este vegetarian\u0103).<br \/>\n\u00cen Europa, unde seconsum\u0103 mult ulei de floarea soarelui, gradul de imunodeficien\u021b\u0103 nu este at\u00e2t de mare ca \u00een Africa. \u00cen unele \u021b\u0103ri din r\u0103s\u0103ritul Europei s-a renun\u021bat la tratamentul cu Butilcarbamazin\u0103. De\u0219i este un antiparazitar eficient, este mai mult imunomodulator \u0219i probabil c\u0103, \u00een acest regim, sistemul imunitar este mai competent.<br \/>\n\u00cen parazitoze, pare c\u0103 este eficient\u0103 cura cu semin\u021be de dovleac, probabi prin con\u021binutul de acizi gra\u0219i polinesatura\u021bi. Este necesar echivalentrul dintr-un kilogram de semin\u021be de dovleac\/zi pentru a se dovedi eficien\u021ba. Acizii gra\u0219i polinesatura\u021bi esen\u021biali au \u0219i rol anticasectizant \u0219i efect antiinflamator \u0219i imunomodulator. Casexia este produs\u0103 \u0219i prin modific\u0103rile metabolice produse citokinele proinflamatorii.<br \/>\nAntigenele parazitare sunt de dou\u0103 tipuri:<br \/>\n\u2022 somatice (polizaharide, glicoproteine, hipoproteine, proteine) \u2013 imunogenicitatea lor este mai sc\u0103zut\u0103 dec\u00e2t la cele metabolice; uneori, se cupleaz\u0103 cu haptenele la diverse structuri \u0219i dau, frecvent, reac\u021bii \u00eencruci\u0219ate, r\u0103spunz\u0103toate de o parte din simptomatologie;<br \/>\n\u2022 antigenele metabolice \u2013 produ\u0219i de secre\u021bie \u0219i excre\u021bie rezulta\u021bi din metabolism; au structuri apropiate de enzimele proteolitice \u0219i lipolitice \u0219i sunt puternic imunogene.<br \/>\nNu sunt descrise structuri glicolitice, ceea ce confirm\u0103 observa\u021bia din medicina popular\u0103 rom\u00e2neasc\u0103 conform c\u0103reia evolu\u021bia este mult \u00eembun\u0103t\u0103\u021bit\u0103 dac\u0103 se scot din alimenta\u021bie zah\u0103rul \u0219i lactatele. Se pare c\u0103 parazi\u021bii utilizeaz\u0103 mai greu glucoza din amidon de aceea asocierea, la tratament, a regimului alimentar de diabet \u00eembun\u0103t\u0103\u021be\u0219te mult evolu\u021bia \u0219i poate salva cazurile letale. De men\u021bionat c\u0103 nu sunt eficiente curele de \u00eenfometare, hipoglicemiante ci, dimpotriv\u0103, o alimenta\u021bie vegetarian\u0103 aleas\u0103 cu grij\u0103.<br \/>\nTratamentul cu Albendazol ac\u021bioneaz\u0103 tot \u00een sensul sc\u0103derii utiliz\u0103rii glucozei prin microtubuli: se leag\u0103 de microtubuli \u0219i inhib\u0103 polimerizarea \u0219i asamblarea microtubulilor, deci asocierea cu un regim f\u0103r\u0103 glucoz\u0103 cu gust dulce \u0219i lactate adue rezultate superioare. Regimul trebuie p\u0103strat, ulterior, ani de zile, probabil c\u0103 toat\u0103 via\u021ba.<br \/>\nUneori, schemele antiparazitare con\u021bin asociate \u0219i glucocorticoizi (exemplu: \u00een toxocaroza ocular\u0103 schea standard cuprinde Albendazol \u0219i glucocorticoizi pentru 5-20 de zile). O asocia\u021bie standard \u00eentre Saprosan 3% \u0219i Triamcinolon acetonid 0,10%, \u00een preparatul Triamcinolon S (unguent topic) m\u0103re\u0219te mult eficien\u021ba antimicoticului. Asocierile care m\u0103resc eficien\u021ba sunt \u00eent\u00e2lnite frecvent la unguente \u0219i mai pu\u021bin la medica\u021bia per os dar probabil c\u0103 ete \u0219i cazul schemelor glucocorticoizi + vitamina D3, glucocorticoizi + Albendazol \u00een toxocaroza ocular\u0103, glucocorticoizi + antituberculostatic \u00een pleurezia TBC (nu \u0219i \u00een pneumonia TBC unde inflama\u021bia este tot intens\u0103), glucocorticoizi + miostin \u00een schema standard de 15 mg Prednisaon (de 3 ori secre\u021bia bazal\u0103 a suprarenalei) \u00een miastenia gravis.<br \/>\nUn alt tip de schem\u0103 a fost propus\u0103 de unii autori cu administrarea Prednisonului \u00eenainte de chimioterapie (\u00een hepatitele virale \u00een ideea de a activa virusul hepatic la un nivel la care s\u0103 fie mai sensibil la ac\u021biunea interferonului). Schema a fost testat\u0103 \u0219i \u00een parazitologie (Prednison \u00eenainte de Albendazol), f\u0103r\u0103 efecte superioare. Pare c\u0103 eficacitatea maxim\u0103 este doar la asocierea din schema standard din toxocaroza ocular\u0103 cu Albendazol concomitent cu Prednison pentru 5-20 de zile.<br \/>\nDup\u0103 observa\u021biile alergologilor, Prednisonul in vitro poate avea, uneori, efecte inverse de imunostimulare, ca \u0219i Ciclofosfamida . ciclofosfamida, la doze foarte mici, poate nhiba lomfocitul Ts (inhibi\u021bie dependent\u0103 de doz\u0103) produc\u00e2nd stimulare. Efectul seam\u0103n\u0103 cu cel exercitat de vaccinarea BCG.<br \/>\n\u00cen parazitoze, durata \u0219i concentra\u021bia chimioterapicului trebuie potrivit\u0103 \u00een func\u021bie de ciclul de dezvoltare al parazitului. La parazi\u021bii dormani nu prea sunt active antiparazitozele antimetabolice iar prelungirea duratei tratamentului poate duce la rezisten\u021b\u0103 (parazitul ingurgit\u00e2nd cronic medicamentul poate dezvolta rezisten\u021b\u0103 de aceea este important a se stabili durata optim\u0103 a tratamentului c\u00e2t mai scurt\u0103).<br \/>\nUnii infec\u021bioni\u0219ti \u0219i parazitolpgi din Ia\u0219i, Rom\u00e2nia, au tratat cazur de urticarie \u0219i angioedem \u00een cadrul toxocarozei cu scheme scurte de Albendazol de 5-7, resepectiv, 10 zile. Psihiatrii au raportat pozitiv\u0103ri ale anticorpilor antitoxocara canis \u00een cursul tratamentului cu Risperidon\u0103 la pacien\u021bi cu psihoze (deziluzia parazitar\u0103). Probabil c\u0103 este vorba de purt\u0103tori asimptomatici de parazi\u021bi dormanzi cu localizare cerebral\u0103 (Risperidona are tropism pentru sistemul nervos central \u0219i posibil s\u0103 ac\u021bioneze \u0219i \u00een parazitozele sistemului nervos central invers dec\u00e2t Ivermectina care nu str\u0103bate bariera hematoencefalic\u0103 \u0219i ac\u021bioneaz\u0103 numai \u00een parazitozele tisulare.<br \/>\n\u00cen Rom\u00e2nia a fost pozitivat \u0219i un caz de toxocaroz\u0103 cu manifest\u0103ri clinice de astenie marcat\u0103 (sindromul oboselii cronice, diagnosticat cu criteriile Gay Holmes \u2013 Atlanta, 1988). Anticorpii antitoxocara canis au fost, initial, nedetectabili dar, ulterior, s-au pozitivat sub tratament de prob\u0103 cu Albendazol paralel cu ameliorarea simptomatologiei clinice. Pare c\u0103 a fost un caz de simdrom al oboselii cronice cu toxocaroz\u0103 cerebral\u0103 cu anticorpi nedetectabili. Exist\u0103 mai multe mecanisme prin care parazi\u021bii eludeaz\u0103 sistemele de ap\u0103rare ale sistemului imun:<br \/>\n\u2022 dorman\u021ba parazitar\u0103 (nu prea exprim\u0103 antigene metabolice iar antigenele somatice nu prea sunt imunogene; cuticula unor parazi\u021bi poate fi lipsit\u0103 de antigenicitate dar poate deveni imunogen\u0103 prin conjugare cu alte componente ale parazi\u021bilor);<br \/>\n\u2022 imunodeficien\u021ba (\u00een lynfocite B \u0219i T macrofage, deficien\u021be ale sistemului complement care duc la alterarea fun\u021biei sistemului imun).<br \/>\n\u00cen concluzie, echilibrarea regimului igieno-dietetic, prin respectarea expunerii la radia\u021bii UV (pare c\u0103 radia\u021biile matinale sunt benefice \u00een \u00eent\u0103rirea sistemului imun) \u0219i introducerea unui regim alimentar vegetarian, f\u0103r\u0103 alimente dulci \u0219i lactate, ar putea avea efecte benefice \u00een tratamentul parazitozelor tropicale, put\u00e2nd, astfel, salva cazuri severe.<\/p>\n<p style=\"text-align: right;\">Mihaela Ghimpu<br \/>\nMedic specialist Imunologie clinic\u0103<br \/>\n\u0219i Alergologie<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00cen parazitozele tisulare severe din zonele tropiale, cele ce evolueaz\u0103 spre casexie \u0219i exitus, mai ales la copii, probabil c\u0103 sunt implica\u021bi mai mul\u021bi factori: ac\u021biunes direct\u0103 a produ\u0219ilor metabolici parazitari, ac\u021biunea sistemului imunitar prin citokine (TNF, IFN) \u0219i ac\u021biunea indirect\u0103 imunologic\u0103 prin cross-reactivity (exemple \u2013 cardiopatia cronic\u0103, esofagita \u0219i [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-55","post","type-post","status-publish","format-standard","hentry","category-perspective-terapeutice"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Perspective terapeutice \u00een parazitozele din Africa - Imunomed<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.imunomed.ro\/?p=55&lang=ro\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Perspective terapeutice \u00een parazitozele din Africa - Imunomed\" \/>\n<meta property=\"og:description\" content=\"\u00cen parazitozele tisulare severe din zonele tropiale, cele ce evolueaz\u0103 spre casexie \u0219i exitus, mai ales la copii, probabil c\u0103 sunt implica\u021bi mai mul\u021bi factori: ac\u021biunes direct\u0103 a produ\u0219ilor metabolici parazitari, ac\u021biunea sistemului imunitar prin citokine (TNF, IFN) \u0219i ac\u021biunea indirect\u0103 imunologic\u0103 prin cross-reactivity (exemple \u2013 cardiopatia cronic\u0103, esofagita \u0219i [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.imunomed.ro\/?p=55&amp;lang=ro\" \/>\n<meta property=\"og:site_name\" content=\"Imunomed\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-04T11:22:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-11-04T14:06:10+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/?p=55&lang=ro#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/?p=55&lang=ro\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/#\\\/schema\\\/person\\\/1c85e72766d24a7ec82815bb2686b618\"},\"headline\":\"Perspective terapeutice \u00een parazitozele din Africa\",\"datePublished\":\"2019-11-04T11:22:55+00:00\",\"dateModified\":\"2019-11-04T14:06:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/?p=55&lang=ro\"},\"wordCount\":1419,\"publisher\":{\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/#\\\/schema\\\/person\\\/1c85e72766d24a7ec82815bb2686b618\"},\"articleSection\":[\"Perspective-terapeutice\"],\"inLanguage\":\"ro-RO\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/?p=55&lang=ro\",\"url\":\"https:\\\/\\\/www.imunomed.ro\\\/?p=55&lang=ro\",\"name\":\"Perspective terapeutice \u00een parazitozele din Africa - Imunomed\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/#website\"},\"datePublished\":\"2019-11-04T11:22:55+00:00\",\"dateModified\":\"2019-11-04T14:06:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/?p=55&lang=ro#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.imunomed.ro\\\/?p=55&lang=ro\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/?p=55&lang=ro#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Prima pagin\u0103\",\"item\":\"https:\\\/\\\/www.imunomed.ro\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Perspective terapeutice \u00een parazitozele din Africa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/#website\",\"url\":\"https:\\\/\\\/www.imunomed.ro\\\/\",\"name\":\"Imunomed\",\"description\":\"Imunitate si alergologie\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/#\\\/schema\\\/person\\\/1c85e72766d24a7ec82815bb2686b618\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.imunomed.ro\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/#\\\/schema\\\/person\\\/1c85e72766d24a7ec82815bb2686b618\",\"name\":\"admin\",\"logo\":{\"@id\":\"https:\\\/\\\/www.imunomed.ro\\\/#\\\/schema\\\/person\\\/image\\\/\"},\"url\":\"https:\\\/\\\/www.imunomed.ro\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Perspective terapeutice \u00een parazitozele din Africa - Imunomed","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.imunomed.ro\/?p=55&lang=ro","og_locale":"ro_RO","og_type":"article","og_title":"Perspective terapeutice \u00een parazitozele din Africa - Imunomed","og_description":"\u00cen parazitozele tisulare severe din zonele tropiale, cele ce evolueaz\u0103 spre casexie \u0219i exitus, mai ales la copii, probabil c\u0103 sunt implica\u021bi mai mul\u021bi factori: ac\u021biunes direct\u0103 a produ\u0219ilor metabolici parazitari, ac\u021biunea sistemului imunitar prin citokine (TNF, IFN) \u0219i ac\u021biunea indirect\u0103 imunologic\u0103 prin cross-reactivity (exemple \u2013 cardiopatia cronic\u0103, esofagita \u0219i [&hellip;]","og_url":"https:\/\/www.imunomed.ro\/?p=55&lang=ro","og_site_name":"Imunomed","article_published_time":"2019-11-04T11:22:55+00:00","article_modified_time":"2019-11-04T14:06:10+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Scris de":"admin","Timp estimat pentru citire":"7 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.imunomed.ro\/?p=55&lang=ro#article","isPartOf":{"@id":"https:\/\/www.imunomed.ro\/?p=55&lang=ro"},"author":{"name":"admin","@id":"https:\/\/www.imunomed.ro\/#\/schema\/person\/1c85e72766d24a7ec82815bb2686b618"},"headline":"Perspective terapeutice \u00een parazitozele din Africa","datePublished":"2019-11-04T11:22:55+00:00","dateModified":"2019-11-04T14:06:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.imunomed.ro\/?p=55&lang=ro"},"wordCount":1419,"publisher":{"@id":"https:\/\/www.imunomed.ro\/#\/schema\/person\/1c85e72766d24a7ec82815bb2686b618"},"articleSection":["Perspective-terapeutice"],"inLanguage":"ro-RO"},{"@type":"WebPage","@id":"https:\/\/www.imunomed.ro\/?p=55&lang=ro","url":"https:\/\/www.imunomed.ro\/?p=55&lang=ro","name":"Perspective terapeutice \u00een parazitozele din Africa - Imunomed","isPartOf":{"@id":"https:\/\/www.imunomed.ro\/#website"},"datePublished":"2019-11-04T11:22:55+00:00","dateModified":"2019-11-04T14:06:10+00:00","breadcrumb":{"@id":"https:\/\/www.imunomed.ro\/?p=55&lang=ro#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.imunomed.ro\/?p=55&lang=ro"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.imunomed.ro\/?p=55&lang=ro#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Prima pagin\u0103","item":"https:\/\/www.imunomed.ro\/"},{"@type":"ListItem","position":2,"name":"Perspective terapeutice \u00een parazitozele din Africa"}]},{"@type":"WebSite","@id":"https:\/\/www.imunomed.ro\/#website","url":"https:\/\/www.imunomed.ro\/","name":"Imunomed","description":"Imunitate si alergologie","publisher":{"@id":"https:\/\/www.imunomed.ro\/#\/schema\/person\/1c85e72766d24a7ec82815bb2686b618"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.imunomed.ro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":["Person","Organization"],"@id":"https:\/\/www.imunomed.ro\/#\/schema\/person\/1c85e72766d24a7ec82815bb2686b618","name":"admin","logo":{"@id":"https:\/\/www.imunomed.ro\/#\/schema\/person\/image\/"},"url":"https:\/\/www.imunomed.ro\/?author=1"}]}},"lang":"ro","translations":{"en":128,"ro":55},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=\/wp\/v2\/posts\/55","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=55"}],"version-history":[{"count":1,"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=\/wp\/v2\/posts\/55\/revisions"}],"predecessor-version":[{"id":56,"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=\/wp\/v2\/posts\/55\/revisions\/56"}],"wp:attachment":[{"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=55"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=55"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.imunomed.ro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=55"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}